MEEDER ASSET MANAGEMENT INC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 129 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 2.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2022$6,000
-92.6%
2,078
-81.9%
0.00%
-100.0%
Q3 2021$81,000
-19.8%
11,457
+3.8%
0.00%
-20.0%
Q2 2021$101,000
+1920.0%
11,035
+1786.3%
0.01%
Q3 2020$5,000
-66.7%
585
-61.7%
0.00%
-100.0%
Q2 2020$15,000
+87.5%
1,529
+64.6%
0.00%0.0%
Q1 2020$8,000
-81.4%
929
-81.3%
0.00%
-66.7%
Q4 2019$43,000
+115.0%
4,958
+169.6%
0.00%
+200.0%
Q3 2019$20,000
+122.2%
1,839
+168.9%
0.00%0.0%
Q2 2019$9,000
+125.0%
684
+564.1%
0.00%
Q1 2019$4,000
+33.3%
103
-26.4%
0.00%
Q4 2018$3,000
-50.0%
140
+12.9%
0.00%
Q3 2018$6,000
-99.9%
124
+61.0%
0.00%
Q2 2018$4,555,000
+12210.8%
77
-79.0%
0.00%
-100.0%
Q4 2017$37,000
+236.4%
366
+315.9%
0.00%
+200.0%
Q3 2017$11,000
+22.2%
88
-11.1%
0.00%0.0%
Q2 2017$9,000
+28.6%
99
-45.3%
0.00%0.0%
Q1 2017$7,000
-53.3%
181
-64.1%
0.00%0.0%
Q4 2016$15,0005040.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q2 2020
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders